Literature DB >> 15084381

Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.

Hartmut Kuhn1, Carmen Köpff, Jana Konrad, Alexander Riedel, Christian Gessner, Hubert Wirtz.   

Abstract

Basic fibroblast growth factor (bFGF) is closely involved in angiogenesis and tumor growth of various cancers, but its role in proliferation and differentiation of non-small cell lung cancer (NSCLC) remains to be defined. The majority of NSCLC cell lines produce elevated protein levels of bFGF but do not secrete comparable amounts. We therefore investigated the influence of bFGF on the proliferation of three human NSCLC cell lines. Our experiments demonstrate that intracellular bFGF level and bFGF mRNA expression correlated with the proliferation rate in all three cell lines. Delivery of a bFGF neutralizing monoclonal antibody, anti-sense oligonucleotides or a vector expressing bFGF antisense cDNA into the cells inhibited tumor cell growth. Delivery of recombinant bFGF into a bFGF-negative cell line led to increased proliferation. These findings suggest that bFGF stimulates the growth of tumor cells by intracrine mechanisms. Strategies to inhibit bFGF in NSCLC may therefore be a promising approach in NSCLC therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084381     DOI: 10.1016/j.lungcan.2003.11.005

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  29 in total

Review 1.  Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

Authors:  S A Kono; L E Heasley; R C Doebele; D R Camidge
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

2.  GPC5 gene and its related pathways in lung cancer.

Authors:  Yafei Li; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

3.  FGFR1 expression and gene copy numbers in human lung cancer.

Authors:  Lukas H Kohler; Masoud Mireskandari; Thomas Knösel; Annelore Altendorf-Hofmann; Almut Kunze; Andreas Schmidt; Norbert Presselt; Yuan Chen; Iver Petersen
Journal:  Virchows Arch       Date:  2012-05-31       Impact factor: 4.064

4.  miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).

Authors:  Xiao-hui Sun; Xiao-lin Geng; Jun Zhang; Chao Zhang
Journal:  Tumour Biol       Date:  2014-11-18

5.  Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.

Authors:  Vitor Sousa; Diana Reis; Maria Silva; Ana Maria Alarcão; Ana Filipa Ladeirinha; Maria João d'Aguiar; Teresa Ferreira; Sandra Caramujo-Balseiro; Lina Carvalho
Journal:  Virchows Arch       Date:  2016-05-19       Impact factor: 4.064

6.  Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.

Authors:  Cigdem Usul Afsar; Berksoy Sahin; Meral Gunaldi; Emine Kılıc Bagir; Derya Gumurdulu; Refik Burgut; Melek Erkisi; Ismail Oguz Kara; Semra Paydas; Feryal Karaca; Vehbi Ercolak
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.

Authors:  Carmen Behrens; Heather Y Lin; J Jack Lee; Maria Gabriela Raso; Waun Ki Hong; Ignacio I Wistuba; Reuben Lotan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.

Authors:  Kathryn E Ware; Marianne E Marshall; Lydia R Heasley; Lindsay Marek; Trista K Hinz; Paula Hercule; Barbara A Helfrich; Robert C Doebele; Lynn E Heasley
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 9.  Targeting angiogenesis in squamous non-small cell lung cancer.

Authors:  Bilal Piperdi; Amartej Merla; Roman Perez-Soler
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

10.  Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.

Authors:  Yongjun Yin; Tomoko Betsuyaku; Joel R Garbow; Jinbai Miao; Ramaswamy Govindan; David M Ornitz
Journal:  Cancer Res       Date:  2013-07-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.